Alpha Profiles · Company Profile

Viking Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/viking-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: VKTX
Verification: Partially verified
Last reviewed: 2026-10-07T06:07:19.437306+00:00

Overview

Alpha's canonical identity and public leadership record for Viking Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Bradley T. Sheares, Ph.D.

President and Chief Executive Officer, Director

State: confirmed
Effective: From Apr 1, 2026
Confidence: 94%
Evidence: VKTX DEF 14A executive officersApr 1, 2026

Greg Zante

Chief Financial Officer

State: confirmed
Effective: From Apr 1, 2026
Confidence: 94%
Evidence: VKTX DEF 14A executive officersApr 1, 2026

Marianne Mancini

Chief Operating Officer

State: confirmed
Effective: From Apr 1, 2026
Confidence: 94%
Evidence: VKTX DEF 14A executive officersApr 1, 2026

Neil Aubuchon

Chief Commercial Officer

State: confirmed
Effective: From Apr 1, 2026
Confidence: 94%
Evidence: VKTX DEF 14A executive officersApr 1, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 7, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.